JOPIC

The JoPIC is an independent-unbiased, peer-reviewed, and open-access journal of current national and international issues and reviews for original clinical and experimental research, interesting case reports, surgical techniques, differential diagnoses, editorial opinions, letters to the editor, and educational papers in pulmonology, thoracic surgery, occupational diseases, allergology, and intensive care medicine.

EndNote Style
Index
Original Article
The effect of CPAP treatment on pulmonary function, anxiety/depression and life quality in obstructive sleep apnea syndrome
Aims: Obstructive sleep apnea syndrome (OSAS) is a condition commonly associated with excessive daytime sleepiness and neurophysiological dysfunction and increases cardiovascular and cerebrovascular morbidity and mortality. Exercise limitation was assessed with a 6 min walk test (6MWT) in previous studies and was associated with apnea hypopnea index (AHI), body mass index (BMI), female gender, hypertension (HT), and low FVC values. There are few studies on the effect of CPAP treatment on these parameters. In our study; the aim of this study was to evaluate the changes in pulmonary function test (PFT), 6MWT, quality of life (SF-36) and hospital anxiety / depression scale with patients who should use CPAP because of OSAS.
Methods: Patients who presented to the Sleep Clinic of the Department of Pulmonology at Hacettepe University Faculty of Medicine between 17 October 2018 and 20 December 2018 were enrolled in the study. Individuals with a diagnosis of sleep apnea who met the indication criteria for positive airway pressure (PAP) therapy underwent titration under polysomnographic supervision, and an appropriate PAP device with optimal pressure settings was prescribed. Demographic characteristics, medical history, anthropometric measurements, and polysomnography (PSG) recordings were collected for all participants. Additionally, the Short Form-36 (SF-36) questionnaire, the Hospital Anxiety and Depression Scale (HADS), the 6-minute walk test (6MWT), and baseline morning spirometry were administered. After obtaining their PAP devices and using them for one month, patients were scheduled for routine follow-up, during which spirometry, the SF-36 questionnaire, HADS, and the 6MWT were reassessed.
Results: 18 patients were included in the study. These patients; 17% were female and 83% were male and the mean age was 46.9 ± 9. The anxiety and depression scores were significantly decreased after one month of CPAP treatment. Before CPAP treatment; anxiety was found in 4 patients and depression was found in 8 patients. One month CPAP treatment; anxiety was present 2 patients and no depression was detected in any patient. In the evaluation of exercise capacity; there was a significant increase in walking distance after CPAP treatment (548,83 ± 60,6, 579,33 ± 54) (p: 0,007). CPAP treatment was significantly improved in subscales of quality of life in general health, physical function, vitality (energy), social function and mental health sub parameters. There was no significant change in spirometric measurements before and after CPAP treatment and titration. There was no significant change in spirometric measurements before and after CPAP treatment and titration. In the correlation analysis, a significant relationship was found between the change in 6MWT and the change in physical function, energy, mental health and anxiety score. At the same time, a significant correlation was found between anxiety and depression improvement and quality of life subscales.
Conclusion: The study demonstrated that even short-term PAP therapy may lead to improvements in several quality-of-life subdomains, anxiety and depression scores, and exercise capacity. Considering the findings of this study, multicenter investigations involving a larger cohort of patients with obstructive sleep apnea syndrome (OSAS), comparing CPAP therapy with alternative treatment modalities and enabling more advanced analyses, would provide a more comprehensive understanding of CPAP-related changes in pulmonary function, quality of life, anxiety and depression, and exercise capacity.


1. Chokroverty S. Overview of sleep & sleep disorders.Indian J Med Res. 2010;131:126-140.
2. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The report of an American Academy of Sleep Medicine Task Force. Sleep. 1999;22(5):667-689.
3. Kielb SA, Ancoli-Israel S, Rebok GW, Spira AP. Cognition in obstructive sleep apnea-hypopnea syndrome (OSAS): current clinical knowledge and the impact of treatment. Neuromolecular Med. 2012;14(3):180-193. doi:10.1007/s12017-012-8182-1
4. Peppard PE, Young T. Exercise and sleep-disordered breathing: an association independent of body habitus. Sleep. 2004;27(3):480-484. doi:10.1093/sleep/27.3.480
5. Lin CC, Hsu Y, Chen YH, Lin CY, Wang Y. Effect of treatment by nasal CPAP on cardiopulmonary exercise test in obstructive sleep apnea syndrome. Lung. 2004;182(4):199-212. doi:10.1007/s00408-004-2502-7
6. Demiral Y, Ergor G, Unal B, et al. Normative data and discriminative properties of short form 36 (SF-36) in Turkish urban population.BMC Public Health. 2006;6:247. doi:10.1186/1471-2458-6-247
7. Aydemir Ö, Güvenir T, Küey L, Kültür S. Validity and reliability of the Turkish version of the Hospital Anxiety and Depression Scale. Turkish J Psychiatry. 1997;8(4):280-287.
8. Kandasamy G, Reddy K, Raj S, et al. Effectiveness of nasal continuous positive airway pressure therapy in patients with obstructive sleep apnea. Int J Health Plann Manage. 2019;34(4):e1593-e1601. doi:10.1002/hpm.2758
9. Sadik A, Ahmet UD, Zeynep ZU, et al. Prevalence and associated factors of sleep-disordered breathing in Turkish adult population. Sleep Biol Rhythms. 2013;11:29-39.
10. Huang KT, Huang YJ, Chou YT, et al. The influence of obesity on different genders in patients with obstructive sleep apnea. Sci World J. 2014;2014:1-7. doi:10.1155/2014/487215
11. Young T, Peppard PE, Taheri S. Excess weight and sleep-disordered breathing. J Appl Physiol. 2005;99(4):1592-1599. doi:10.1152/japplphysiol. 00587.2005
12. Franklin KA, Gislason T, Omenaas E, et al. The influence of active and passive smoking on habitual snoring. Am J Respir Crit Care Med. 2004; 170(7):799-803. doi:10.1164/rccm.200404-474OC
13. Wetter DW, Young TB, Bidwell TR, Badr MS, Palta M. Smoking as a risk factor for sleep-disordered breathing. Arch Intern Med. 1994;154(19): 2219-2224.
14. The Tobacco Atlas, Turkey. [Internet]. Available from: https://tobaccoatlas. org/country/turkey/. Accessed March 13, 2019.
15. Cholidou KG, Kallianos A, Papageorgiou E, et al. Heart rate recovery post six-minute walking test in obstructive sleep apnea. Clin Res Cardiol. 2014;103(10):805-815. doi:10.1007/s00392-014-0721-3
16. Schlosser B, Wichmann M, Teschler H. Improvement of cardiopulmonary exercise capacity in patients with obstructive sleep apnea syndrome under CPAP therapy. Med Klin (Munich). 2006;101(2): 107-113. doi:10.1007/s00063-006-1015-y
17. Lin CC, Hsu Y, Chen YH, Lin CY, Wang Y. Effect of treatment by nasal CPAP on cardiopulmonary exercise test in obstructive sleep apnea syndrome. Lung. 2004;182(4):199-212. doi:10.1007/s00408-004-2502-7
18. Bonsignore MR, Marrone O, Insalaco G, Bonsignore G. Baroreflex control of heart rate during sleep in severe obstructive sleep apnoea: effects of acute CPAP. Eur Respir J. 2006;27(1):128-135. doi:10.1183/09031936. 06.00042904
19. Ben Saad H, Ben Hassen I, Ghannouchi I, et al. Six-minute walk test data in severe obstructive sleep apnea-hypopnea syndrome under continuous positive airway pressure treatment. Respir Med. 2015;109(5): 642-655. doi:10.1016/j.rmed.2015.03.001
20. Tapan ÖO, Yıldız T, Erdem N, et al. Effect of nasal continuous positive airway pressure therapy on the functional respiratory parameters and cardiopulmonary exercise test in obstructive sleep apnea syndrome. Turk Thorac J. 2016;17(1):1-6. doi:10.5578/ttj.17.1.001
21. Bonay M, Nitenberg A, Maillard D. Should flow-volume loop be monitored in sleep apnea patients treated with continuous positive airway pressure? Respir Med. 2003;97(7):830-834. doi:10.1016/s0954-6111(03)00039-8
22. El-Ad B, Lavie P. Effect of sleep apnea on cognition and mood. Int Rev Psychiatry. 2005;17(4):277-282. doi:10.1080/09540260500104508
23. Schlosshan D, Elliott MW. Clinical presentation and diagnosis of the obstructive sleep apnoea hypopnoea syndrome. Thorax. 2004;59(4):347-352. doi:10.1136/thx.2003.007179
24. Lacasse Y, Godbout C, Series F. Health-related quality of life in obstructive sleep apnoea. Eur Respir J. 2002;19(3):499-503. doi:10.1183/ 09031936.02.00216902
25. Gupta MA, Simpson FC. Obstructive sleep apnea and psychiatric disorders: a systematic review. J Clin Sleep Med. 2015;11(2):165-175. doi: 10.5664/jcsm.4466
26. Celik M, Yalcin S, Ozdemir C, et al. Effect of continuous positive airway pressure treatment on depression, anxiety, and perceived stress levels in patients with obstructive sleep apnea syndrome. Turk Psikiyatri Derg. 2016;27(4):244-250.
27. Coman AC, Borzan CM, Todea DA, Pop CM. Obstructive sleep apnea syndrome and the quality of life. Clujul Med. 2016;89(3):390-395. doi: 10.15386/cjmed-593
28. Irer B, Celikhisar A, Celikhisar H, Bozkurt O, Demir Ö. Evaluation of sexual dysfunction, lower urinary tract symptoms, and quality of life in men with obstructive sleep apnea syndrome and efficacy of continuous positive airway pressure therapy. Urology. 2018;121:66-71. doi:10.1016/j.urology.2018.08.001
29. Finn L, Young T, Palta M. Sleep-disordered breathing and self-reported general health status in the Wisconsin Sleep Cohort Study. Sleep. 1998; 21(7):701-706.
Volume 3, Issue 4, 2025
Page : 108-114
_Footer